Therefore, this research explored potential genes with prognostic value related to Tolerogenic dendritic cells in gastric cancer, to identify novel therapeutic targets that could provide valuable insights for the clinical treatment of gastric cancer.<h4>Results</h4>Five prognostic genes (CXCL1, INHBA, ASCL2, RNASE1, and GPX3) were finally obtained to construct the risk model. Here, RNASE1 is linked to gastric cancer.